OWC Pharmaceutical Research Corp. announced it signed an agreement for $300,000 with Medmar LLC. According to the terms of the agreement: The funds will be allocated to complete the development of the Company's proprietary psoriasis cream; Medmar will have exclusive right to manufacture, produce, publicize, promote and market OWC's Licensed Products in any state in the U.S; The loan is non-interest bearing and will be repaid from royalties generated by the sale of OWC licensed products.